Johnson Matthey (LON:JMAT) Research Coverage Started at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft started coverage on shares of Johnson Matthey (LON:JMAT) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a GBX 2,400 ($30.15) price objective on the stock.

Other equities analysts have also recently issued reports about the stock. Berenberg Bank upped their target price on shares of Johnson Matthey from GBX 1,650 ($20.73) to GBX 1,800 ($22.61) and gave the company a hold rating in a research note on Monday, April 8th. Jefferies Financial Group restated a buy rating and issued a GBX 2,100 ($26.38) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. Finally, Numis Securities restated a buy rating and issued a GBX 2,200 ($27.64) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of GBX 1,993.33 ($25.04).

Johnson Matthey Price Performance

LON JMAT opened at GBX 1,884.70 ($23.68) on Wednesday. The company has a current ratio of 1.51, a quick ratio of 0.76 and a debt-to-equity ratio of 63.95. The company has a fifty day simple moving average of GBX 1,754.12 and a 200 day simple moving average of GBX 1,650.95. The company has a market cap of £3.46 billion, a P/E ratio of 1,927.84, a P/E/G ratio of 49,242.50 and a beta of 0.98. Johnson Matthey has a 1 year low of GBX 1,428.50 ($17.95) and a 1 year high of GBX 1,964 ($24.67).

Insider Activity

In other Johnson Matthey news, insider Stephen Oxley bought 24 shares of Johnson Matthey stock in a transaction dated Wednesday, February 21st. The shares were bought at an average price of GBX 1,597 ($20.06) per share, with a total value of £383.28 ($481.51). In the last quarter, insiders have acquired 66 shares of company stock valued at $114,288. 0.57% of the stock is currently owned by insiders.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.